Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance.
- NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_assertion description "[Truncation mutations of ASXL1 occur in colorectal cancers with microsatellite instability (MSI), malignant myeloid diseases, chronic lymphocytic leukaemia, head and neck squamous cell carcinoma, and liver, prostate and breast cancers; those of ASXL2 occur in prostate cancer, pancreatic cancer and breast cancer and those of ASXL3 are observed in melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance.
- NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_assertion evidence source_evidence_literature NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance.
- NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_assertion SIO_000772 23736028 NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance.
- NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_assertion wasDerivedFrom befree-20150227 NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance.
- NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_assertion wasGeneratedBy ECO_0000203 NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP950332.RA2mElri9BmvIlH2soOA7-ZczPpI1Fg3Grd7Yce3M0sWA130_provenance.